EtoposideAntineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantCisplatinDoxorubicinCombined Modality TherapyCyclophosphamideAntineoplastic AgentsAntineoplastic Agents, PhytogenicTreatment OutcomeIfosfamideCarboplatinDrug Administration ScheduleLung NeoplasmsDisease-Free SurvivalSurvival AnalysisBleomycinSurvival RateNeoadjuvant TherapyTopoisomerase II InhibitorsNeoplasm StagingCytarabineBreast NeoplasmsDrug Resistance, NeoplasmPrognosisMethotrexatePaclitaxelVinblastinePodophyllotoxinDNA Topoisomerases, Type IITesticular NeoplasmsTransplantation, AutologousCarcinoma, Small CellNeoplasm Recurrence, LocalSalvage TherapyGerminomaHodgkin DiseaseNeoplasmsLymphoma, Non-HodgkinLeukopeniaInduction ChemotherapyNeoplasms, Germ Cell and EmbryonalNeutropeniaVincristineMitoxantroneCarmustineCamptothecinTaxoidsInfusions, IntravenousAmsacrineAntineoplastic Agents, AlkylatingCarcinoma, Non-Small-Cell LungDeoxycytidineOrganoplatinum CompoundsAntimetabolites, AntineoplasticMelphalanGranulocyte Colony-Stimulating FactorDose-Response Relationship, DrugOvarian NeoplasmsFollow-Up StudiesApoptosisAntibiotics, AntineoplasticTeniposideTime FactorsNeoplasm MetastasisHematopoietic Stem Cell TransplantationAnthracyclinesRadiotherapy, AdjuvantNauseaVomitingThrombocytopeniaAdenocarcinomaDaunorubicinCell Line, TumorBrain NeoplasmsHematologic DiseasesAdministration, OralChemotherapy, Cancer, Regional PerfusionRecurrenceDrug EvaluationDacarbazineProspective StudiesThiotepaBone NeoplasmsRadiotherapyRetroperitoneal NeoplasmsP-GlycoproteinLomustineLeukemia, Myeloid, AcuteDrug Resistance, MultipleClinical Trials as TopicKaplan-Meier EstimateTumor Cells, CulturedTopotecanOsteosarcomaLymphomaMitomycinColorectal NeoplasmsRadiotherapy DosagePrecursor Cell Lymphoblastic Leukemia-Lymphoma